Skip to main content
FUSION ANTIBODIES PLC logo

FUSION ANTIBODIES PLC — Investor Relations & Filings

Ticker · FAB ISIN · GB00BDQZGK16 LEI · 213800KBAYRC9VOQ9V39 IL Professional, scientific and technical activities
Open in API
Filings indexed 301 across all filing types
Latest filing 2021-03-10 Regulatory Filings
Country GB United Kingdom
Listing IL FAB

About FUSION ANTIBODIES PLC

https://www.fusionantibodies.com/

Fusion Antibodies PLC is a contract research organization (CRO) that provides a comprehensive suite of services for the discovery, engineering, and supply of preclinical biologics. The company offers an integrated, end-to-end antibody development platform, spanning from initial antigen design and antibody generation to advanced engineering processes like humanization and affinity maturation. It also provides services for the supply of recombinant proteins and antibodies, including stable cell line development. Fusion Antibodies supports therapeutic and diagnostic programs, operating as a collaborative partner to guide projects through critical preclinical stages with a focus on long-term manufacturability and commercialization.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1936 characters) and contains the header 'RNS Number : 7770R'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA). This type of immediate, operational market announcement that doesn't fit a standard financial report category (like 10-K, ER, or IR) is best classified as a general Regulatory Filing (RNS), as it is a direct communication to the market via the official regulatory news service.
2021-03-10 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1919 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security, referencing the 'National Storage Mechanism' and 'RNS Number : 7764R'. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This structure—a brief notification about a market event or administrative update distributed via the RNS system—fits best under the general regulatory announcement category, as it is not a comprehensive report (like 10-K or IR) nor a specific corporate action like a dividend or management change. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-03-10 English
Exercise of Options and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is identified by the header 'RNS Number : 5304R' and contains standard boilerplate language from RNS, the news service of the London Stock Exchange. The content announces the 'Exercise of Options and Total Voting Rights' following the issuance of new ordinary shares due to option exercises. This type of announcement, which details changes in the total number of voting rights and is distributed via RNS, fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). Since it is a formal regulatory announcement distributed through the official channel (RNS), and doesn't fit a more specific category like DIRS or SHA (though it relates to share issuance, the primary focus is the resulting voting rights notification), RNS is the most appropriate general regulatory filing code.
2021-03-08 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the header 'RNS Number : 4006Q' and contains information about the company's total voting rights (25,562,025 ordinary shares). This type of announcement, which provides a mandatory regulatory update regarding share capital structure and voting rights denominator, is typically disseminated via the Regulatory News Service (RNS) of the London Stock Exchange. While it relates to share capital, it is not a formal share issue/change announcement (SHA) or a transaction in own shares (POS), but rather a routine disclosure required under transparency rules. Since it is a general regulatory announcement disseminated via RNS and doesn't fit precisely into the other specific categories (like ER, 10-K, DIV, etc.), the most appropriate classification is the general regulatory filing category, RNS.
2021-02-26 English
Directorate Change
Board/Management Information Classification · 99% confidence The document is a regulatory announcement filed via RNS (RNS Number: 1736P) dated February 16, 2021. The primary content announces the appointment of a new CEO (Dr Richard Jones) and the resignation of the previous CEO (Dr Paul Kerr), along with details regarding the exercise of options by the outgoing CEO and the resulting change in total voting rights. The announcement of a change in senior management directly corresponds to the definition of 'Board/Management Information' (MANG). While it is distributed via RNS, the specific content is management-related, making MANG the most precise classification.
2021-02-16 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document starts with an 'RNS Number' and is dated 12 February 2021. The content explicitly details a 'Holding in Company' change, specifically noting that an individual, Paul Warwick, holds 814,080 ordinary shares, representing 3.2 per cent. of the issued share capital. This type of filing, reporting personal share transactions by executives or directors (insider trades), directly corresponds to the definition of 'Director's Dealing' (DIRS). Although it is distributed via RNS, the specific content dictates the primary classification. Checking the definitions: - DIRS: Report of personal share transactions by company directors and executives (insider trades). This is a perfect match. - MRQ: Major Shareholding Notification is for changes in significant ownership levels, but DIRS is more specific for director/insider transactions. - RNS: This is the distribution channel, not the content type. Therefore, the most accurate classification is DIRS.
2021-02-12 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.